Literature DB >> 6124442

Influence of labetalol, propranolol and practolol in patients with asthma.

K Larsson.   

Abstract

The acute effect of non-selective beta-blockade alone (propranolol) or in combination with alpha-blockade (labetalol) and beta 1-selective blockade (practolol) on the airways was studied in 14 asthmatic patients. Severe bronchoconstriction was not seen in any patient after placebo (saline) or practolol (10 mg i.v.) while pronounced bronchoconstriction was seen in three patients after labetalol (20 mg i.v.) and in six patients after propranolol (5 mg i.v.). The effects of 2 weeks of oral medication with labetalol (200 mg x 2) and placebo were studied in the same patients. Four patients had symptoms of asthma during the labetalol period while none had asthmatic symptoms during the placebo period. The results suggest that coexistent alpha-adrenoceptor blockade fails to prevent asthmatic symptoms caused by beta-blockade.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124442

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  5 in total

1.  Failure of enhancement by labetalol of bronchopulmonary effects of histamine in guinea-pigs: independence of alpha-adrenoceptor antagonism.

Authors:  C Clerici; A Harf; I Macquin-Mavier
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

2.  Evaluation of I.V. labetalol for treatment of posttraumatic hyperdynamic state.

Authors:  D R Morel; A Forster; P M Suter
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

3.  Respiratory function in the elderly and the effects of beta blockade.

Authors:  A E Tattersfield
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

Review 4.  Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Authors:  K L Goa; P Benfield; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 5.  Electroimmunology and cardiac arrhythmia.

Authors:  Jana Grune; Masahiro Yamazoe; Matthias Nahrendorf
Journal:  Nat Rev Cardiol       Date:  2021-03-02       Impact factor: 32.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.